Outcomes of Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome in COVID-19 Patients: A Propensity-Matched Analysis.
COVID-19
SARS-CoV-2
acute respiratory distress syndrome
coagulation
extracorporeal membrane oxygenation
thromboembolic events
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
09 Jun 2021
09 Jun 2021
Historique:
received:
09
05
2021
revised:
21
05
2021
accepted:
07
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
3
7
2021
Statut:
epublish
Résumé
It remains unclear to what extent the outcomes and complications of extracorporeal membrane oxygenation (ECMO) therapy in COVID-19 patients with acute respiratory distress syndrome (ARDS) differ from non-COVID-19 ARDS patients. In an observational, propensity-matched study, outcomes after ECMO support were compared between 19 COVID-19 patients suffering from ARDS (COVID group) and 34 matched non-COVID-19 ARDS patients (NCOVID group) from our historical cohort. A 1:2 propensity matching was performed based on respiratory ECMO survival prediction (RESP) score, age, gender, bilirubin, and creatinine levels. Patients' characteristics, laboratory parameters, adverse events, and 90-day survival were analyzed. Patients' characteristics in COVID and NCOVID groups were similar. Before ECMO initiation, fibrinogen levels were significantly higher in the COVID group (median: 493 vs. 364 mg/dL,
Identifiants
pubmed: 34207573
pii: jcm10122547
doi: 10.3390/jcm10122547
pmc: PMC8227073
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Chim Acta. 2020 Aug;507:167-173
pubmed: 32348783
Semin Thromb Hemost. 2015 Feb;41(1):91-8
pubmed: 25590526
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
Biosci Trends. 2020 Sep 21;14(4):285-289
pubmed: 32350161
Artif Organs. 2021 Jun;45(6):E158-E170
pubmed: 33236373
JAMA. 2018 Dec 4;320(21):2251-2259
pubmed: 30347031
Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:69-80
pubmed: 22552982
Intensive Care Med. 2020 Jun;46(6):1154-1169
pubmed: 32328725
Thromb Res. 2020 Dec;196:186-192
pubmed: 32891904
Lancet Respir Med. 2019 Feb;7(2):163-172
pubmed: 30642776
Ann Intern Med. 2020 Sep 1;173(5):350-361
pubmed: 32422076
Lancet. 2020 Oct 10;396(10257):1071-1078
pubmed: 32987008
Ann Intern Med. 2020 Aug 18;173(4):268-277
pubmed: 32374815
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
ASAIO J. 2020 Jul;66(7):707-721
pubmed: 32604322
J Clin Med. 2020 May 07;9(5):
pubmed: 32392741
N Engl J Med. 1999 Feb 11;340(6):409-17
pubmed: 9971864
JAMA. 2011 Oct 19;306(15):1659-68
pubmed: 21976615
J Thromb Haemost. 2005 Apr;3(4):692-4
pubmed: 15842354
J Crit Care. 2020 Aug;58:27-28
pubmed: 32279018